By Michael Gwarisa Nearly seven in ten Zimbabweans who previously used daily oral HIV prevention pills abandoned treatment because of the burden of taking medication every day, a new survey has revealed, adding fresh evidence that long-acting injectable HIV prevention could transform the country’s fight against new HIV infections. The findings come just months after
Read More
By Michael Gwarisa Malawi has received its first shipment of lenacapavir, a long-acting injectable HIV prevention medicine, with enough doses expected to protect 38,000 people, marking another milestone in Africa’s rollout of one of the most significant advances in HIV prevention in decades. The arrival of the first of two planned shipments positions Malawi as
Read More
By Michael Gwarisa A groundbreaking Zimbabwean study has revealed that older people living with HIV have significantly poorer bone health than their HIV-negative peers, with women facing an even greater risk of developing osteoporosis and suffering debilitating fractures as they age. Published in the Journal of Bone and Mineral Research, the study found that HIV
Read More
Kuda Pembere in Bulawayo Bulawayo Metropolitan Province recorded strong uptake of Voluntary Medical Male Circumcision (VMMC) in 2024, with the highest coverage achieved among males aged 25 to 29 and 15 to 19 years, according to the National AIDS Council (NAC). VMMC remains one of Zimbabwe’s key HIV prevention strategies, with studies showing that medical
Read More
Kuda Pembere in Bulawayo A rise in sexually transmitted infections (STIs) among young people aged between 10 and 24 years is prompting the National AIDS Council (NAC) to intensify HIV prevention programmes in Magwegwe District, one of Bulawayo’s areas with identified HIV hotspots. For NAC programming purposes, Magwegwe District encompasses Magwegwe, Pumula and Lobengula suburbs
Read More
Kuda Pembere in Bulawayo Mawaba Primary School says it is determined to preserve the gains achieved through the DREAMS programme, including a dramatic reduction in child sexual abuse cases, despite the suspension of funding for the initiative. School authorities say the programme helped establish a Gender-Based Violence (GBV) room and strengthened child protection systems, contributing
Read More
Michael Gwarisa Zimbabwe is set to significantly expand access to Lenacapavir, the long-acting injectable HIV prevention drug, after securing additional financial support from the Global Fund through the United States Department of State, a development expected to strengthen HIV prevention efforts among high-risk populations. The new support will see an additional 43,000 doses added to
Read More
Michael Gwarisa Canada has recorded its first possible HIV cure in a 62-year-old man who has remained in sustained remission following a bone marrow transplant, according to a report from the University of Toronto. The case, known as the “Toronto patient,” was developed through a collaboration between clinicians and researchers at University Health Network, Unity
Read More
Michael Gwarisa Mozambique yesterday joined other African countries that have introduced and added Lenacapavir, a long-acting injectable HIV prevention drug, into their biomedical prevention methods. Other countries that have introduced the HIV prevention drug include Eswatini, Kenya, Lesotho, Nigeria, South Africa, Uganda, Zambia, and Zimbabwe. In Mozambique, the official launch was hosted at the
Read More